News about "Orchard Therapeutics, Pharming team up to develop"

Orchard Therapeutics, Pharming team up to develop and commercialize HSC gene therapy to treat hereditary angioedema

Orchard Therapeutics, Pharming team up to develop and commercialize HSC gene therapy to treat hereditary angioedema

Orchard Therapeutics, a global gene therapy leader, and Pharming Group NV, a global and commercial stage biopharmaceutical company, have jointly announced a strategic collaboration to research, develop, manufacture and commercialize OTL-105

Orchard Therapeutics, Pharming Team Up To Develop | 02/07/2021 | By Darshana 317


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members